Search

Search Constraints

You searched for: Author/Creator Schuuring, Ed

Search Results

2. Addition of tumour infiltration depth and extranodal extension improves the prognostic value of the pathological TNM classification for early‐stage oral squamous cell carcinoma. Issue 3 (29th July 2019)

4. Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET/CT scanning and immunohistochemistry. Issue 1 (October 2015)

5. Assessment of hypoxic subvolumes in laryngeal cancer with 18F-fluoroazomycinarabinoside (18F-FAZA)-PET/CT scanning and immunohistochemistry. Issue 1 (October 2015)

6. Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review. (23rd April 2020)

7. Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Issue 1 (10th July 2019)

8. Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors. Issue 11 (25th September 2021)

9. Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation. (August 2020)

10. Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer. Issue 5 (23rd September 2020)